HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double-helical CT as a new tool for tracking of allograft atherosclerosis in heart transplant recipients.

AbstractRATIONALE AND OBJECTIVES:
Tracking the progression of allograft atherosclerosis in heart transplant recipients is currently accomplished using invasive techniques. If its monitoring feasibility is demonstrated, spiral CT could be a non-invasive alternative for this objective.
METHODS:
Twenty-four consecutive heart transplant patients (21 men, 3 women, mean age 55 +/- 11 years) were scanned using double-helical CT. The first scan was performed 1.9 +/- 1.3 years after transplantation. After 2 years of follow-up, 4 patients died and the remaining 20 underwent a second scan. All scans were performed according to a previously reported double-helical CT protocol.
RESULTS:
The incidence of coronary calcification at the first scan was 4.2% (1/24); it increased to 40% (8/20) at the second scan (P < 0.001). Spiral CT identified new but very mild calcific deposits in seven patients with a mean total calcium score of 6.7 +/- 4.0.
CONCLUSIONS:
Double-helical CT is a viable tool to diagnose and track newly developed allograft atherosclerosis.
AuthorsJ Shemesh, A Tenenbaum, C I Stroh, S Apter, Y Har-Zahav, E Z Fisman, Y Itzchak, M Motro
JournalInvestigative radiology (Invest Radiol) Vol. 34 Issue 7 Pg. 485-8 (Jul 1999) ISSN: 0020-9996 [Print] United States
PMID10399639 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adult
  • Coronary Angiography
  • Coronary Artery Disease (complications, diagnostic imaging)
  • Female
  • Follow-Up Studies
  • Graft Occlusion, Vascular (diagnostic imaging, etiology)
  • Heart Transplantation
  • Humans
  • Male
  • Middle Aged
  • Reproducibility of Results
  • Tissue Donors
  • Tomography, X-Ray Computed
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: